Clinical trials

  • CYCLOPHOSPHAMIDE for Luminal B breast cancer
  • PENTIXATHER; YTTRIUM-90 for Primary central nervous system lymphoma | Secondary central nervous system lymphoma
  • SODIUM HYDROGEN CARBONATE for Labor induction | Childbirth
  • Colchicine for Peripheral arterial disease | Intermittent claudication
  • WVE-006 for Alpha-1 antitrypsin deficiency (AATD) | Alpha-1 antitrypsin deficiency (Pi*ZZ)
  • Loncastuximab tesirine for Relapsed or refractory B-cell non-Hodgkin lymphoma
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Giant cell arteritis | Polymyalgia rheumatica
  • DEFERIPRONE for Pelizaeus-Merzbacher disease
  • SIROLIMUS for Familial adenomatous polyposis
  • Tolinapant (ASTX660) for Locally advanced rectal cancer
  • Isoflurane for Intracranial hemorrhage | Severe traumatic brain injury | Ischemic stroke | Hemorrhagic stroke
  • Clodronate disodium for Knee osteoarthritis